QID 317130

Date Published: 2022-02-03

QID 317130: Cisco Internetwork Operating System (IOS) XE SD-WAN Software Command Injection Vulnerability (cisco-sa-sdwan-maapi-privesc-KSUg7QSS)

A vulnerability in the CLI of Cisco IOS XE SD-WAN Software could allow an authenticated,
local attacker to inject arbitrary commands to be executed with root-level privileges on the underlying operating system.

Affected Products:
Following Cisco products if they are running a vulnerable release of Cisco IOS XE SD-WAN Software and have the SD-WAN feature enabled:
1000 Series Integrated Services Routers (ISRs)
4000 Series ISRs
ASR 1000 Series Aggregation Services Routers
Cloud Services Router 1000V Series
Note: The SD-WAN feature is not enabled by default.

QID Detection Logic (Authenticated):
The check matches Cisco IOS XE SDWAN version retrieved via Unix Auth using "show version" command.
QID Detection Logic (Unauthenticated):
The check matches Cisco IOS XE version retrieved via SNMP or TCP/IP Fingerprint or NTP or Telnet.

A successful exploit could allow the attacker to execute commands with root-level privileges.

  • CVSS V3 rated as High - 6.7 severity.
  • CVSS V2 rated as High - 7.2 severity.
    • Solution

    Customers are advised to refer to cisco-sa-sdwan-maapi-privesc-KSUg7QSS for more information.

    Vendor References

    CVEs related to QID 317130

    CVE-2021-34725 |
    Software Advisories
    Advisory ID Software Component Link
    cisco-sa-sdwan-maapi-privesc-KSUg7QSS URL Logo tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-sdwan-maapi-privesc-KSUg7QSS
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].